Data concerning the action of specific antiherpes immunoglobulins on the evolution of some nasopharyngeal and larynegeal neoplasms.
The administration of specific antiherpes immunoglobulins (Ig) to 9 patients with nasopharyngeal and laryngeal neoplasms resulted in the regression of metastatic lymph nodes, the absence of other metastatic localizations and the survival--in a good general state--of all the patients treated, for 23-29 months. Most of the patients received no other treatment during this time interval. In a control group consisting of 11 patients with the same forms of cancer, but who received no Ig, 4 fatal outcomes were recorded and all patients required re-hospitalization and application of other treatments. The method suggested may represent an efficient adjuvant therapy in some nasopharyngeal and laryngeal neoplasms.